Budget impact analysis of a bioprosthetic valve with a novel tissue versus mechanical aortic valve replacement in patients older than 65 years with aortic stenosis in Saudi Arabia.

João L Carapinha Hussain Abdulrahman Al-OmarUthman AluthmanTurki B AlbackerAmr ArafatKhaled AlgarniBelén Martí-Sánchez

Published in: Journal of medical economics (2022)

An AVR in patients > 65 years with a RESILIA tissue valve is budget-saving from the first year in Saudi Arabia. Patients, payers, providers and policymakers may benefit economically from increased implantation of RESILIA tissue valves.

Keyphrases

aortic stenosis
ejection fraction
aortic valve replacement
aortic valve
end stage renal disease
transcatheter aortic valve implantation
newly diagnosed
transcatheter aortic valve replacement
mitral valve
left ventricular
heart failure